// App-Quantinova.ai

e19025 : Circulating tumor cells enrichment and characterization in ALK-translocation positive lung cancer.

Researchers

Presenter

  • Patrick C. Ma

Principal Investigators

  • Lihong Yin

  • Powrnima Joshi

  • Wei Zhang

  • Marc A. Shapiro

  • Michael J. McNamara

  • Nooshin Hashemi

  • Nathan A. Pennell

  • Ernest C. Borden

  • Maciej Zborowski

  • Yan Feng

  • Barbara Jacobs

Medical Centers

  • Cleveland Clinic, Cleveland, OH

  • University Hospitals Case Western Reserve University, Cleveland, OHCleveland Clinic Foundation, Cleveland, OHCleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Taussig Cancer Institute Cleveland Clinic, Cleveland, OH

  • Cleveland Clinic Lerner Research Institute, Cleveland, OH

  • Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Red Blood Cells

Drug/Treatment

  • Crizotinib

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved